New Key Statistics Module, Z-Score and F-Score
HKSE:02616 Key Ratios
| Market Cap HK$ M | 1,377.34 |
| Enterprise Value HK$ M | 659.88 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.77 |
| Price/Sales | 2.46 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) HK$ M | 531.00 |
| EPS (TTM) HK$ | -0.70 |
| Beneish M-Score | -1.61 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 32.80 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.91 |
| EV-to-EBITDA | -0.93 |
| PEG | -- |
| Shares Outstanding M | 1,275.32 |
| Net Margin (%) | -156.83 |
| Operating Margin % | -161.26 |
| Pre-tax Margin (%) | -156.83 |
| Quick Ratio | 1.44 |
| Current Ratio | 1.56 |
| ROA % (ttm) | -45.68 |
| ROE % (ttm) | -166.38 |
| ROIC % (ttm) | -97.52 |
| Dividend Yield % | -- |
| Altman Z-Score | -7.04 |
HKSE:02616 Number of Guru Trades
HKSE:02616 Volume of Guru Trades
Gurus Latest Trades with HKSE:02616
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
HKSE:02616 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
CStone Pharmaceuticals Insider Transactions
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers